Phycocyanin prevents methylglyoxal-induced mitochondrial-dependent apoptosis in INS-1 cells by Nrf2

Yingnv Gao1, Chen Liu1, Guoqing Wan1

  • 1School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, China. ouyu2008@126.com.

Food & Function
|January 26, 2016
PubMed

Insights

Phycocyanin (PC) protects pancreatic beta cells from methylglyoxal (MG)-induced apoptosis by preventing mitochondrial dysfunction. PC activates the Nrf2 pathway, reducing oxidative stress and preserving beta cell function in Type 2 diabetes models.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Endocrinology

Background:

  • Methylglyoxal (MG), a reactive dicarbonyl compound, accumulates in diabetes and causes pancreatic beta-cell damage.
  • Beta-cell dysfunction and apoptosis are key features of Type 2 diabetes, often linked to mitochondrial dysfunction.
  • Phycocyanin (PC) exhibits diverse biological activities, including potential benefits in diabetic models.

Purpose of the Study:

  • To investigate the protective effects of Phycocyanin (PC) against methylglyoxal (MG)-induced pancreatic beta-cell (INS-1) dysfunction.
  • To elucidate the underlying mechanisms of PC's protective action against MG-induced mitochondrial damage and apoptosis.

Main Methods:

  • Assessment of mitochondrial dysfunction markers: ATP levels, intracellular reactive oxygen species (ROS).
  • Analysis of apoptosis pathways: cytochrome c and AIF release, Bcl-2 family expression, caspase activation, PARP cleavage.
  • Investigation of PC's mechanism: Nrf2 activation, HO-1 and Glo-1 expression, RNA interference.

Main Results:

  • MG induced mitochondrial dysfunction, characterized by decreased ATP and increased ROS levels in INS-1 cells.
  • MG triggered mitochondrial-dependent apoptosis, involving cytochrome c/AIF release and caspase activation.
  • PC treatment attenuated MG-induced apoptosis and mitochondrial dysfunction, linked to Nrf2 activation and increased HO-1/Glo-1 expression.

Conclusions:

  • Phycocyanin (PC) demonstrates a protective effect against methylglyoxal (MG)-induced mitochondrial dysfunction and apoptosis in pancreatic beta cells.
  • The protective mechanism of PC involves the activation of the Nrf2 pathway, leading to enhanced antioxidant enzyme activity.
  • PC holds potential for therapeutic intervention in Type 2 diabetes by safeguarding beta-cell function from glycation stress.